WSJ: Pfizer considering buying Global Blood Therapeutics for roughly $5 billion

Shares of Global Blood Therapeutics Inc. GBT, +38.65% jumped 9.5% in trading on Friday after The Wall Street Journal reported that Pfizer Inc. PFE, -0.97% is considering buying the company for about $5 billion. There were media reports earlier this week that Global Blood Therapeutics, which markets a sickle-cell treatment, is attracting takeover interest. The company’s stock is up 79.6% this year, while the broader S&P 500 SPX, -0.63% is down 12.8%.

 » Read More  » Read More

Tags: No tags

Comments are closed.